510(k) device
HydroMARK Breast Biopsy Site Marker
Devicor Medical Products, Inc. · Marker, Radiographic, Implantable (NEU, Class II) · First FDA decision May 5, 2016, newest Apr 21, 2022Breast cancer
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
510(k) pathway
Device trials
2
Naming "HydroMARK Breast Biopsy"
MAUDE reports
43
Brand "HydroMARK Breast Biopsy", since 2015
PubMed studies
0
Mentioning "HydroMARK Breast Biopsy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing HydroMARK Breast Biopsy Site Marker
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
K212158 · Decided Apr 21, 2022 · 283 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
K210752 · Decided Apr 14, 2021 · 30 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
K203097 · Decided Dec 16, 2020 · 63 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "HydroMARK Breast Biopsy", any status and sponsor, newest update first.
University of Alabama at BirminghamAcademic, hospital or other
NCT06294574 · 150 participants (planned) · Start Aug 5, 2025 · Primary completion Dec 2027
Device: HydroMARK Plus Clip · For: Breast Neoplasm
Sites: Birmingham, Alabama
King Hussein Cancer CenterAcademic, hospital or other
NCT05836337 · 54 participants · Start Feb 1, 2017 · Primary completion Nov 20, 2019
Device: Tattoo- Black Eye; clip- HydroMARK · For: Breast Cancer
Sites: Amman, Jordan
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "HydroMARK Breast Biopsy", and for the whole product code for context.
This brand
43 reports: 4 malfunction, 39 injury, 0 death
Whole product code NEU
1,678 reports: 518 malfunction, 1,149 injury, 1 death
Newest reports for this brand
- HYDROMARK BREAST BIOPSY SITE MARKERMalfunction
DEVICOR MEDICAL PRODUCTS, INC.
MW5190848 · Received Jul 20, 2026 · Event dated Jul 10, 2026
Device type: Marker, Radiographic, Implantable (NEU)
Patient problem as coded: Foreign Body In Patient
3008492462-2023-00012 · Received Nov 6, 2023 · Event dated Oct 17, 2023
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hypersensitivity/Allergic reaction
3008492462-2023-00009 · Received Aug 10, 2023 · Event dated Jul 11, 2023
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Use of Device Problem
Patient problem as coded: Foreign Body In Patient
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- HydroMARK Breast Biopsy Site Marker, Model Number: 4010-02-15-T3Open, Classified
Z-2239-2026 · Started Apr 24, 2026 · Posted by FDA May 27, 2026
Reason given: Incorrect inner package labeling. Boxes labeled 4010-02-15-T3 markers may contain individual packages labeled as T4 Markers.
Cause as FDA categorized it: Labeling mix-ups · Device type: Marker, Radiographic, Implantable (NEU)
Z-1124-2022 · Started Mar 30, 2022
Reason given: Small patient labels do not match the primary device label. The primary device label accurately identifies the product as 4010-05-08-T4, while the smaller patient label incorrectly identifies the product as 4010-05-08-T3.
Cause as FDA categorized it: Labeling Change Control · Device type: Marker, Radiographic, Implantable (NEU)
Published research
The most relevant PubMed records for "HydroMARK Breast Biopsy"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NEU.
- MOLLI 2 SystemMolli Surgical, Inc. · 510(k) 2024
- HydroMARK Plus Breast Biopsy Site Marker (Dragonfly Shape)Devicor Medical Products, Inc. · 510(k) 2026
- UltraCor Twirl Breast Tissue MarkerBard Peripheral Vascular, Inc. · 510(k) 2025
- RFID Localization SystemHealth Beacons, Inc. · 510(k) 2020
- Cianna Medical SAVI Scout Reflector and SAVI Scout SystemCianna Medical, Inc. · 510(k) 2018
- Beacon Tissue Marker (SE)Scion Medical Technologies, LLC · 510(k) 2015
- Biopsy Sciences, Inc. Hydromark Brest Biosy Site MarkerBiopsy Sciences, LLC · 510(k) 2012
- Securmark Biopsy Site Marking SystemSuros Surgical Systems, Inc. A Hologic Company · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.